Trial intelligence / Profile preview

Multicenter open-label study of Nestorone/Ethinyl Estradiol contraceptive vaginal ring

2005-004978-25Phase 3Active

Sponsor
International Committee for Contraception Research
Start
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of annovera in contraception, sponsored by International Committee for Contraception Research. Primary endpoint: Pearl Index per 100 woman-years for women ≤ 35 years. Started Jul 2006; status: active.

02

Drugs

annovera
03

Conditions

contraception

Beyond the preview

Go deeper on 2005-004978-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004978-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call